PTPRC, PPARG, PTGS2 and CCR2 emerged as top‐ranking nodes in the network, suggesting their pivotal roles in the molecular mechanism underlying DBD's therapeutic effects against RA. This evidence concerns the gene CCR2 and rheumatoid arthritis.